Defining Notch signaling mechanisms associated with the cardiovascular phenotypes of Alagille Syndrome
ESGO eAcademy. Thomas S. 10/25/21; 343914; 512
CLICK HERE TO LOGIN
PREMIUM CONTENT
PREMIUM CONTENT
Access to Premium content is currently a membership benefit.
Click here to join ESGO or renew your membership.
Apple
Google (online)
Office 365 (online)
Outlook
Outlook.com (online)
Yahoo
Abstract
Discussion Forum (0)
Co-Author: Lilly, Brenda J. ; Thomas, Shelby E. (Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States);
Presenter: Thomas, Shelby E. (Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States);
Alagille syndrome is a genetic disorder caused by mutations in the Notch signaling ligand Jagged1. Liver abnormalities are a major feature of the disease, but patients exhibit a range of defects in other organs, including the eyes, kidneys, skeletal, and
Co-Author: Lilly, Brenda J. ; Thomas, Shelby E. (Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States);
Presenter: Thomas, Shelby E. (Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States);
Alagille syndrome is a genetic disorder caused by mutations in the Notch signaling ligand Jagged1. Liver abnormalities are a major feature of the disease, but patients exhibit a range of defects in other organs, including the eyes, kidneys, skeletal, and
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}